Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry. - Barreiro-de Acosta M; Zabana Y; Nieto-García L; Poncela M; Aguas M; Martínez-Cuevas C; Argüelles-Arias F; Calvo M; Gargallo-Puyuelo CJ; Zabalza L; Trastoy PV; Boscá-Watts MM; et al. (Alimentary pharmacology & therapeutics, 2026)